Methylation Microarray

CD Genomics is a world-leading company that can provide the best microarray products and solutions for global customers in the field of epigenetics research. We have successfully completed many related microarray projects and can provide the best products and services to customers all over the world.

Methylation Microarray

Methylation Microarray is an effective methylation high-throughput screening technology that can capture the methylation changes of a single base. We provide 2 specifications of methylated microarray products. The detection range of the array covers gene coding regions, including CpG islands and promoter regions, and even includes some unusual methylation sites outside of CpG islands. Each sample can detect more than 850,000 differentially methylated cytosine sites. It can be used for the determination of non-CpG methylation sites identified in human stem cells, microRNA promoter regions, and methylation sites that are differentially expressed in tumors and normal tissues.

Application of Methylation Microarray

DNA methylation is the most important field in epigenetics research and is closely related to many diseases. Processes such as regulation and differentiation, development, genetic imprinting, X chromosome inactivation, and tissue-specific maintenance through methylation modification. The occurrence and development of complex diseases such as cancer, nervous system diseases, and diabetes are closely related to DNA methylation. In the post-genomic era, due to the reduction in the cost of high-throughput technologies, research fronts tend to adopt multi-perspective combinatorial analysis. From genetics and epigenetics to transcriptome and metabolome, from mechanism to phenotype, conduct integrated research to obtain global results. Our array products can directly and accurately detect methylation sites with high technical repeatability. In addition, we also provide professional methylation data analysis software, which can promote the personalized analysis of scientific researchers.


  • Unique design. The probe design is based on the public methylation database and our own database, which can meet most of the needs, and can also customize the product for you;
  • Widely used. Our products can be used for global methylation feature analysis, or to assist methylation detection in specific areas;
  • High cost performance. High-throughput detection function can save cost, labor, and time.

CD Genomics provides high-quality array products and services for epigenetics and methylation modification research. With a large team of scientists and a well-equipped test platform, we are committed to cooperating with customers all over the world to meet your specific requirements. We have comprehensive design and production capabilities to provide broad and comprehensive services for academic and industrial research. If you are interested in our services, please contact us for more details.

Our products and services are for research purposes ONLY. We do not perform any private testing services that are not for laboratory use.
Cat# Product Name Inquiry Basket
+ CDME-3 Custom Methylation DNA Microarray Online Inquiry
Description: Creating your own custom Methylation microarrays. Choose from multiple array formats and focus on your specific research needs. You can design new probes using algorithms, upload your own sequences, or just select from our database of catalog probes.
+ CDME-1 Human DNA Methylation Microarray Online Inquiry
Description: Differentially Methylated Cytosines, >850,000 methylation sites per sample at single-nucleotide resolution
+ CDME-2 Human DNA Methylation Microarray Online Inquiry
Description: Human DNA Methylation microarrays enable analysis of DNA methylation, leading to a greater understanding of the epigenetic events that regulate gene transcription. The Microarray is specifically designed for analysis of methylated DNA derived from methylated DNA immunoprecipitation (MDIP). The probes have been selected to maximize coverage and quality, enabling analysis of approximately 28,500 CpG islands with median resolution of 97 bp.
CD Genomics
Headquartered in New York, USA,
CD Genomics is cooperating with hundreds of institutions and marketing its products and services in multiple countries.
Contact Info



Inquiry Basket